ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,331Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 107

$737K Total Retail Price of All Prescriptions

Rank: 18 out of 107

395 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

7% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,146 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 464 396 1 1
FUROSEMIDE 356 339 2 3
METOPROLOL TARTRATE 316 289 3 7
WARFARIN SODIUM 298 298 4 8
LISINOPRIL 270 241 5 4
METFORMIN HCL 269 224 6 13
OMEPRAZOLE 268 250 7 6
SIMVASTATIN 263 223 8 2
ATORVASTATIN CALCIUM 249 228 9 17
PRAVASTATIN SODIUM 243 209 10 32
AMLODIPINE BESYLATE 243 236 10 5
METOPROLOL SUCCINATE 192 186 12 15
HYDROCHLOROTHIAZIDE 146 118 13 14
SERTRALINE HCL 145 134 14 12
PANTOPRAZOLE SODIUM 140 107 15 28
NAMENDA 137 137 16 19
GABAPENTIN 133 97 17 11
CITALOPRAM HBR 125 125 18 9
DONEPEZIL HCL 114 114 19 10
ATENOLOL 103 96 20 21
TRAMADOL HCL 103 100 20 23
DIOVAN 101 95 22 33
RISPERIDONE 100 100 23 26
POTASSIUM CHLORIDE 100 78 23 18
ISOSORBIDE MONONITRATE ER 94 94 25 30
KLOR-CON M20 87 70 26 45
ENALAPRIL MALEATE 85 85 27 70
LANTUS 82 82 28 34
ALLOPURINOL 81 76 29 48
MIRTAZAPINE 80 80 30 16
CLOPIDOGREL 80 76 30 29
EVISTA 77 77 32 176
DIOVAN HCT 74 66 33 137
TRICOR 69 63 34 148
RANITIDINE HCL 69 59 34 41
ESCITALOPRAM OXALATE 66 64 36 40
CELEBREX 66 62 36 82
TAMSULOSIN HCL 62 61 38 27
LIPITOR 60 54 39 132
PLAVIX 60 55 39 43
NOVOLOG 57 57 41 76
NEXIUM 56 53 42 61
BENICAR 56 54 42 183
CARVEDILOL 55 55 44 25
EXELON 55 55 44 111
GLIPIZIDE 52 40 46 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 28, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.